Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection.
Koji FujitaNoriyuki KurodaAsahiro MorishitaKyoko OuraTomoko TadokoroTakako NomuraHirohito YoneyamaTakeshi AraiTakashi HimotoSeishiro WatanabeTsutomu MasakiPublished in: Journal of clinical medicine (2018)
Fib-4 index and APRI were comparable with WFA-M2BP and ELF score in the diagnosis of advanced liver fibrosis in Japanese patients with HCV infection. All four biomarkers of liver fibrosis were influenced by histopathological activity grading, which implies that liver biopsy should be the gold standard to evaluate liver fibrosis staging even though several noninvasive biomarkers have been investigated well.